Your browser doesn't support javascript.
loading
[Clinical value of ultrasound-guided radiofrequency ablation in the treatment of retroperitoneal tumors].
Peng, M F; Li, Y Y; Qi, Q H; Dong, G; Zhang, S S; Zhang, Y A.
Afiliación
  • Peng MF; Department of Ultrasound, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Li YY; Department of Ultrasound, Pingdingshan Hospital of Traditional Chinese Medicine, Pingdingshan 467099, China.
  • Qi QH; Department of Ultrasound, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Dong G; Department of Ultrasound, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Zhang SS; Department of Ultrasound, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Zhang YA; Department of Ultrasound, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
Zhonghua Zhong Liu Za Zhi ; 44(5): 442-445, 2022 May 23.
Article en Zh | MEDLINE | ID: mdl-35615802
Objective: To explore the clinical value of ultrasound-guided radiofrequency ablation in the treatment of retroperitoneal tumors. Methods: The clinical data of 13 patients with retroperitoneal tumors treated with ultrasound-guided radiofrequency ablation in the First Affiliated Hospital of Zhengzhou University from January 2018 to January 2020 were analyzed retrospectively. The ablation effect was evaluated and the postoperative complications were observed. The changes of tumor volume before and after radiofrequency ablation were compared. Results: The symptoms of pain and dyspepsia were significantly improved after radiofrequency ablation, and the hospital stay was (9.2±2.9) days. The tumor was ablated completely in 10 cases, tumor residual in 1 case and tumor metastasis in 2 cases. One patient had postoperative duodenal perforation complicated with intra-abdominal infection, and no serious complications occurred in other patients. There were 20 lesions in 13 patients. The maximum diameter of 20 lesions before operation and 1, 3, 6 months after operation were (39.5±15.9) mm, (30.6±4.9)mm, (15.6±7.7) mm and (9.9±3.1) mm, respectively, the maximum diameters of 1, 3 and 6 months after operation were smaller than that before operation (P<0.05). Conclusion: Ultrasound-guided radiofrequency ablation is a real-time, accurate, safe and effective minimally invasive treatment with few complications, and has a high clinical value for retroperitoneal tumors.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Retroperitoneales / Ablación por Catéter / Ablación por Radiofrecuencia Tipo de estudio: Observational_studies Límite: Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Retroperitoneales / Ablación por Catéter / Ablación por Radiofrecuencia Tipo de estudio: Observational_studies Límite: Humans Idioma: Zh Revista: Zhonghua Zhong Liu Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China